To address this challenge, a novel cell-type-specific ferroptosis inducer, N6F11, was developed to selectively target cancer cells by binding to tripartite motif-containing 25 (TRIM25) and promoting TRIM25-dependent degradation of GPX4[22]. This evidence concerns the gene GPX4 and cancer.